IP Library Granted Patent US 11,708,587
Granted Patent B2
US 11,708,587 · App. 17/929,646 · Granted Jul 25, 2023

Compositions and methods for increasing the efficiency of cell cultures used for food production

Inventors: Nicholas J. Genovese (Hayward, CA); Eric N. Schulze (San Francisco, CA); Danielle Nicole Desmet (Berkeley, CA)
Assignee: UPSIDE FOODS, INC.
C12N15/87C07K14/65C07K14/76C12N5/0602C12N9/1276C12N9/93A23L35/00C12N2501/60C12Y603/01002
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,708,587
App. No.
17/929,646
Granted
Jul 25, 2023
Kind
B2
Abstract

Provided herein are compositions and methods to make and use engineered cells, for the purpose of increasing the cell density of a culture comprising metazoan cells and for the production of a cultured edible product.

Claims (51)

1. A method for manufacturing an edible metazoan biomass comprising cells having myogenic or fibroblastic capacity, the method comprising:

a) obtaining the cells from a master cell bank, wherein the cells are suspended in a cryopreservation media in a cryovial, and further wherein the cells:

are capable of renewal,

overexpress a Glutamine Synthase (GS) gene, an Insulin-like Growth Factor (IGF) gene, an albumin gene, or a combination thereof,

overexpress one or more myogenic transcription factors, and

are from a livestock, poultry, or game animal species;

b) removing the cryopreservation media;

c) suspending the cells in a cell culture media;

d) culturing the cells on a cultivation substrate in the cell culture media;

e) permitting cells to proliferate until the cells reach confluence;

f) inducing the cells to at least partially differentiate into myocytes and multinucleated myotubes using a differentiation medium;

g) forming the myocytes and multinucleated myotubes into skeletal muscle fibers; and

h) processing the skeletal muscle fibers to form the edible metazoan biomass.

2. The method of claim 1 , wherein the cryovial is rapidly thawed to room temperature.

3. The method of claim 1 , wherein the cryopreservation media is removed from the cryovial using 300×g centrifugation for 5 minutes.

4. The method of claim 1 , wherein the cultivation substrate is gelatin-coated.

5. The method of claim 1 , wherein inducing the at least partial differentiation comprises at least partially differentiating the cells for up to 6 days.

6. The method of claim 1 , wherein the one or more myogenic transcription factors are selected from MYOD1, MYOG, MYF5, MYF6, PAX3, and PAX7.

7. The method of claim 1 , wherein the cells are derived from a duck.

8. A method for manufacturing an edible metazoan biomass comprising cells having myogenic or fibroblastic capacity, the method comprising:

a) obtaining the cells suspended in a cryopreservation medium, wherein the cells:

are capable of renewal,

overexpress a Glutamine Synthase (GS) gene, an Insulin-like Growth Factor (IGF) gene, an albumin gene, or a combination thereof,

overexpress one or more myogenic transcription factors, and

are from a livestock, poultry, or game animal species;

b) removing the cryopreservation media and collecting the cells;

c) adding growth media to the cells;

d) culturing the cells in adherent culture for a growth period;

e) inducing the cells to at least partially differentiate into skeletal muscle cells using a differentiation medium; and

f) harvesting the skeletal muscle cells after the growth period to form the edible metazoan biomass.

9. The method of claim 8 , wherein the cells comprise anchorage-dependent cells and are grown on a substrate.

10. The method of claim 8 , wherein differentiation comprises at least partially differentiating the cells for up to 6 days.

11. The method of claim 8 , wherein the one or more myogenic transcription factors are selected from MYOD1, MYOG, MYF5, MYF6, PAX3, and PAX7.

12. The method of claim 8 , wherein the cells are derived from a duck.

13. A method for manufacturing an edible metazoan biomass comprising stem cells, the method comprising:

a) obtaining the stem cells that are suspended in a cryopreservation media,

wherein the cells:

are capable of renewal,

overexpress a Glutamine Synthase (GS) gene, an Insulin-like Growth Factor (IGF) gene, an albumin gene, or a combination thereof,

overexpress one or more myogenic transcription factors, and

are from a livestock, poultry, or game animal species; and

b) removing the cryopreservation media and collecting the stem cells;

c) adding growth media to the stem cells;

d) culturing the stem cells in adherent culture after a growth period;

e) inducing the stem cells to at least partially differentiate into myocytes and multinucleated myotubes using a differentiation medium;

f) forming the myocytes and multinucleated myotubes into skeletal muscle fibers; and

g) processing the skeletal muscle fibers after the growth period to form the edible metazoan biomass.

14. The method of claim 13 , wherein the stem cells are mesenchymal stem cells.

15. The method of claim 13 , wherein inducing the stem cells to at least partially differentiate into myocytes and multinucleated myotubes comprises at least partially differentiating the cells for up to 6 days.

16. The method of claim 13 , wherein the one or more myogenic transcription factors are selected from MYOD1, MYOG, MYF5, MYF6, PAX3, and PAX7.

17. The method of claim 13 , wherein the cells are derived from a poultry or a game species.

Assignments (3)
CHANGE OF NAME Recorded Jun 9, 2026
From: UPSIDE FOODS, INC.
To: THE UPSIDE GROUP INC.
Reel/Frame 075827/0954 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 10, 2023
From: GENOVESE, NICHOLAS J.; SCHULZE, ERIC N.; DESMET, DANIELLE N.
To: MEMPHIS MEATS, INC.
Reel/Frame 062941/0745 →
CHANGE OF NAME Recorded Mar 10, 2023
From: MEMPHIS MEATS, INC.
To: UPSIDE FOODS, INC.
Reel/Frame 063029/0347 →
Continuity (3)
Continuation 16630404
Provisional Application 62532345 · Jul 13, 2017
Related Publication 20230002789A1 · Jan 5, 2023
Cited By (2)
US 12,668,774 US 12,686,847